Lafond C - Search Results

1

A deep learning model to generate synthetic CT for prostate MR-only radiotherapy dose planning: a multicenter study.

Tahri S, Texier B, Nunes JC, Hemon C, Lekieffre P, Collot E, Chourak H, Le Guevelou J, Greer P, Dowling J, Acosta O, Bessieres I, Marage L, Boue-Rafle A, De Crevoisier R, Lafond C, Barateau A. Tahri S, et al. Among authors: lafond c. Front Oncol. 2023 Nov 28;13:1279750. doi: 10.3389/fonc.2023.1279750. eCollection 2023. Front Oncol. 2023. PMID: 38090490 Free PMC article.

2

Pseudo-CT Generation for MRI-Only Radiation Therapy Treatment Planning: Comparison Among Patch-Based, Atlas-Based, and Bulk Density Methods.

Largent A, Barateau A, Nunes JC, Lafond C, Greer PB, Dowling JA, Saint-Jalmes H, Acosta O, de Crevoisier R. Largent A, et al. Among authors: lafond c. Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):479-490. doi: 10.1016/j.ijrobp.2018.10.002. Epub 2018 Oct 16. Int J Radiat Oncol Biol Phys. 2019. PMID: 30336265

3

Comparison of Deep Learning-Based and Patch-Based Methods for Pseudo-CT Generation in MRI-Based Prostate Dose Planning.

Largent A, Barateau A, Nunes JC, Mylona E, Castelli J, Lafond C, Greer PB, Dowling JA, Baxter J, Saint-Jalmes H, Acosta O, de Crevoisier R. Largent A, et al. Among authors: lafond c. Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):1137-1150. doi: 10.1016/j.ijrobp.2019.08.049. Epub 2019 Sep 7. Int J Radiat Oncol Biol Phys. 2019. PMID: 31505245

4

Planning With Patient-Specific Rectal Sub-Region Constraints Decreases Probability of Toxicity in Prostate Cancer Radiotherapy.

Lafond C, Barateau A, N'Guessan J, Perichon N, Delaby N, Simon A, Haigron P, Mylona E, Acosta O, de Crevoisier R. Lafond C, et al. Front Oncol. 2020 Sep 11;10:1597. doi: 10.3389/fonc.2020.01597. eCollection 2020. Front Oncol. 2020. PMID: 33042802 Free PMC article.

5

Quality assurance for MRI-only radiation therapy: A voxel-wise population-based methodology for image and dose assessment of synthetic CT generation methods.

Chourak H, Barateau A, Tahri S, Cadin C, Lafond C, Nunes JC, Boue-Rafle A, Perazzi M, Greer PB, Dowling J, de Crevoisier R, Acosta O. Chourak H, et al. Among authors: lafond c. Front Oncol. 2022 Oct 10;12:968689. doi: 10.3389/fonc.2022.968689. eCollection 2022. Front Oncol. 2022. PMID: 36300084 Free PMC article.

6

Computed tomography synthesis from magnetic resonance imaging using cycle Generative Adversarial Networks with multicenter learning.

Texier B, Hémon C, Lekieffre P, Collot E, Tahri S, Chourak H, Dowling J, Greer P, Bessieres I, Acosta O, Boue-Rafle A, Guevelou JL, de Crevoisier R, Lafond C, Castelli J, Barateau A, Nunes JC. Texier B, et al. Among authors: lafond c. Phys Imaging Radiat Oncol. 2023 Nov 17;28:100511. doi: 10.1016/j.phro.2023.100511. eCollection 2023 Oct. Phys Imaging Radiat Oncol. 2023. PMID: 38077271 Free PMC article.

7

Interindividual registration and dose mapping for voxelwise population analysis of rectal toxicity in prostate cancer radiotherapy.

Dréan G, Acosta O, Lafond C, Simon A, de Crevoisier R, Haigron P. Dréan G, et al. Among authors: lafond c. Med Phys. 2016 Jun;43(6):2721-2730. doi: 10.1118/1.4948501. Med Phys. 2016. PMID: 27277019 Free article.

8

The benefit of using bladder sub-volume equivalent uniform dose constraints in prostate intensity-modulated radiotherapy planning.

Zhu J, Simon A, Haigron P, Lafond C, Acosta O, Shu H, Castelli J, Li B, De Crevoisier R. Zhu J, et al. Among authors: lafond c. Onco Targets Ther. 2016 Dec 12;9:7537-7544. doi: 10.2147/OTT.S116508. eCollection 2016. Onco Targets Ther. 2016. PMID: 28003767 Free PMC article.

9

Is Dose Deformation-Invariance Hypothesis Verified in Prostate IGRT?

Simon A, Le Maitre A, Nassef M, Rigaud B, Castelli J, Acosta O, Haigron P, Lafond C, de Crevoisier R. Simon A, et al. Among authors: lafond c. Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):830-838. doi: 10.1016/j.ijrobp.2016.12.011. Epub 2016 Dec 12. Int J Radiat Oncol Biol Phys. 2017. PMID: 28244420

10

Multi-atlas-based segmentation of prostatic urethra from planning CT imaging to quantify dose distribution in prostate cancer radiotherapy.

Acosta O, Mylona E, Le Dain M, Voisin C, Lizee T, Rigaud B, Lafond C, Gnep K, de Crevoisier R. Acosta O, et al. Among authors: lafond c. Radiother Oncol. 2017 Dec;125(3):492-499. doi: 10.1016/j.radonc.2017.09.015. Epub 2017 Oct 12. Radiother Oncol. 2017. PMID: 29031609 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page